6 Statements are based on information licensed from IQVIA for the time periods referenced above, reflecting estimated of real-world activity
Khan said that, aside from diabetes and weight loss, studies have shown GLP-1s reduce major adverse cardiovascular events, help prevent the onset of diabetes and also improve sleep apnea, arthritis and fatty liver disease outcomes
The dosage of these other agents may need to be reduced to lower the risk of low blood sugar levels
Use the right concentration
It wouldnt be surprising, but we need the data to be able to say for sure
Moving from Zepbound to Retatrutide, or vice versa, sometimes produces additional weight loss, likely reflecting differences in individual receptor sensitivity